SCHEMBL24310446

SCHEMBL24310446

c1ccc(Oc2cc(Oc3ccccc3)nc(NSc3ccccc3)n2)cc1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 3/20 0.46
CYP1A2 P05177 3/20 0.46
CYP2C9 P11712 3/20 0.46
CYP2C19 P33261 3/20 0.46
GPR39 O43194 1/20 0.43
HTT P42858 3/20 0.43
MEN1 O00255 2/20 0.43
KMT2A Q03164 2/20 0.43
MAPK1 P28482 3/20 0.42
TDP1 Q9NUW8 1/20 0.42
NUDT1 P36639 1/20 0.42
HPGD P15428 2/20 0.41
L3MBTL1 Q9Y468 2/20 0.41
ATM Q13315 1/20 0.41
HAO1 Q9UJM8 1/20 0.39
ALDH1A1 P00352 4/20 0.38
KDM4E B2RXH2 1/20 0.37
HSD17B10 Q99714 1/20 0.37
TSHR P16473 2/20 0.36
NPSR1 Q6W5P4 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24310755 0.90 MAPT (0.41) MAPTCYP1A2CYP2C9CYP2C19GPR39
SCHEMBL24309752 0.88 MAPK1 (0.57) MAPTCYP1A2CYP2C9CYP2C19GPR39
SCHEMBL24309620 0.86 MAPT (0.41) MAPTCYP1A2CYP2C9CYP2C19GPR39
SCHEMBL24309989 0.85 MAPT (0.40) MAPTCYP1A2CYP2C9CYP2C19GPR39
SCHEMBL24309979 0.84 MAPT (0.40) MAPTCYP1A2CYP2C9CYP2C19GPR39
SCHEMBL24310009 0.83 GPR39 (0.45) MAPTCYP1A2CYP2C9CYP2C19GPR39
SCHEMBL24310766 0.81 GPR39 (0.44) MAPTCYP1A2CYP2C9CYP2C19GPR39
SCHEMBL24310122 0.81 GPR39 (0.49) MAPTCYP1A2CYP2C9CYP2C19GPR39
SCHEMBL24310176 0.80 MAPK1 (0.51) MAPTCYP1A2CYP2C9CYP2C19GPR39
SCHEMBL24309405 0.78 HTT (0.41) MAPTCYP1A2CYP2C9CYP2C19HTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2022076627-A1 MODULATORS OF CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR VERTEX PHARMACEUTICALS INCORPORATED (US) 2022-04-14 WO disclosed